Recordati offers both prescription and OTC products in a wide range of therapeutic areas.

Recordati’s flagship product is ZANIDIP® (lercanidipine), a latest generation calcium-channel blocker for the treatment of hypertension. It is a lipophilic dihydropyridine, discovered and entirely developed by Recordati, with the following characteristics: natural once a day, potent, long-lasting vasodilatory activity, highly vasoselective with gradual onset, smooth and uniform blood pressure lowering activity and improved tolerability over other dihydropyridines.

We offer a wide range of innovative pharmaceuticals in specifc therapeutic areas:

• Antibiotics and Antivirals
• Cardiovascular
• Central nervous system
• Dermatological
• Gastroenterology
• Genito-urinary system
• Muscolo-skeletal disorders and pain therapy
• Obstetics and Gynaecology
• OTC (non-prescription pharmaceuticals)